Lipid-polymer based complexation and delivery of nucleic acids

US12344693B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12344693-B2
Application numberUS-202217892637-A
CountryUS
Kind codeB2
Filing dateAug 22, 2022
Priority dateApr 16, 2019
Publication dateJul 1, 2025
Grant dateJul 1, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel polymers, crosslinked polymer-nucleic acid complexes, lipid-polymer-nucleic acid-based complexation and nanoassemblies, and nanoassembly-based intracellular delivery of nucleic acids and controlled release thereof upon degradation of the nanoassemblies in response to specific microenvironment in the cell, and compositions and methods of preparation and use thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A molecular assembly, comprising: a crosslinked polymer-nucleic acid complex comprising a nucleic acid encapsulated in a crosslinked polymer network; and a coating on the crosslinked polymer-nucleic acid complex, wherein the coating comprises a zwitterionic lipid and a PEGylated lipid. 2. The molecular assembly of claim 1 , wherein the crosslinked polymer-nucleic acid complex comprises: a crosslinked block or random copolymer comprising structural units of: wherein each of R 1 and R′ 1 is independently a hydrogen, C 1 -C 12 alkyl group, or halogen; each of R 2 , R′ 2 , R 3 , and R′ 3 is independently a hydrogen, C 1 -C 16 alkyl, C 1 -C 16 alkyloxy, or halogen; each of L 1 and L 2 is independently a linking group; each of S 1 and S 2 is independently a single bond or a spacer group; W is a hydrophobic group; and X is a group comprising a crosslinking moiety; and a nucleic acid molecule entrapped in the crosslinked block or random copolymer. 3. The molecular assembly of claim 2 , wherein the block or random copolymer further comprises the structural unit of: wherein R″ 1 is a hydrogen, C 1 -C 12 alkyl group, or halogen; each of R″ 2 and R″ 3 is independently a hydrogen, C 1 -C 16 alkyl, C 1 -C 16 alkyloxy, or halogen; L 3 is a linking group; S 3 is a single bond or a spacer group; and Y is a non-crosslinking group. 4. The molecular assembly of claim 2 , wherein X comprises a crosslinked group. 5. The molecular assembly of claim 2 , wherein X comprises a group capable of forming a crosslinking bond. 6. The molecular assembly of claim 2 , wherein the nucleic acid molecule is selected from single-standed or double-stranded RNA or DNA, and derivatives or anologs thereof. 7. The molecular assembly of claim 2 , wherein the nucleic acid molecule is selected from dsRNA, siRNA, mRNA, ncRNA, microRNA, catalytic RNA, gRNA, DNAs, oligonucleotides, aptamers, genes, plasmids, and derivatives or anologs thereof. 8. The molecular assembly of claim 7 , wherein the nucleic acid molecule is an siRNA. 9. The molecular assembly of claim 2 , wherein the copolymer is a random copolymer. 10. The molecular assembly of claim 2 , wherein the copolymer is a block copolymer. 11. The molecular assembly of claim 2 , wherein W comprises a C 1 -C 30 linear or branched alkyl group. 12. The molecular assembly of claim 2 , wherein each of L 1 , L 2 and L 3 is independently a group. 13. The molecular assembly of claim 2 , wherein X comprises a disulfide group. 14. The molecular assembly of claim 2 , wherein the block or random copolymer further comprises the structural unit of: wherein X′ comprises a group selected from: wherein R is a C 1 -C 15 alkyl group, and Z is a counter ion. 15. The molecular assembly of claim 2 , being crosslinked both inter-molecularly and intra-molecularly. 16. The molecular assembly of claim 2 , wherein the zwitterionic lipid comprises a zwitterionic group selected from the group consisting of: wherein each R is hydrogen or a C 1 -C 15 alkyl group; n is independently an integer from about 1 to about 12. 17. The molecular assembly of claim 16 , wherein each n is independently an integer from about 2 to about 6.

Assignees

Inventors

Classifications

  • A61K47/543Primary

    Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title

  • Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

  • and containing nitrogen · CPC title

  • Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12344693B2 cover?
The invention provides novel polymers, crosslinked polymer-nucleic acid complexes, lipid-polymer-nucleic acid-based complexation and nanoassemblies, and nanoassembly-based intracellular delivery of nucleic acids and controlled release thereof upon degradation of the nanoassemblies in response to specific microenvironment in the cell, and compositions and methods of preparation and use thereof.
Who is the assignee on this patent?
Univ Massachusetts
What technology area does this patent fall under?
Primary CPC classification A61K47/543. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).